ReviewInternational journal of molecular sciences2025
The Etiology of Moebius Syndrome-Making the Case for Animal Models.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moebius syndrome (MBS) is a rare disease consisting of uni-/bilateral palsy of CN VI and VII without impairment of vertical eye movements. Its uncommon nature means that the etiology is still uncertain. It is thought to be caused by vascular lesions leading to infarction in the nuclei of cranial nerves VI and VII on the posterior aspect of the pons. However, several genes have also been discussed as possibly causative. We performed a literature search in the PUBMED database and on the Science Direct platform with terms related to the pathology and to each etiology individually. Included were original papers and review articles published in peer-reviewed international journals and reference books and databases on the subjects discussed. We excluded articles not published in English, conference communications, dissertations, monographs, and other non-peer-reviewed forms of publication. The total number of publications thus included was 62. This review discusses the functions of the three most related genes found in recent research (PLXND1, REV3L, TUBB3) and the results of animal studies focusing on their mutations. We note that the PLXND1 and REV3L mutations have been most associated with MBS and that the current studies on their function suggest histological lesions similar to the target disease, albeit without clear phenotypic expression. We ascertain that TUBB3 mutations are mostly related to CEFOM3, which is a differential diagnosis for MBS. Regarding the vascular etiology, we review the types of lesions involved and discuss their timing in relation to embryologic stages. We also highlight the main investigation methods available. A multitude of the factors discussed might be causative of MBS, and we thus consider it necessary to attempt the development of an animal model for the disease. To this end, we propose the development of transgenic mice models containing the single nucleotide mutations documented in human patients, and we discuss the use of the chick embryo model for the vascular etiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.